BSEInsider Trading / SAST4d ago · 26 Aug 2026, 04:48 pm

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August ....

Aster DM Quality Care Ltd · 540975

✦ AI SummaryPledge

Aster DM Quality Care Ltd has disclosed creation of indirect encumbrance over 1,99,80,522 shares (2.29% of total share capital) by Union (Mauritius) Holdings Limited to secure term loan facilities of USD 160,000,000 and USD 50,000,000.

Analysis Scores

Earnings Impact2/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aster DM Quality Care Ltd - 540975 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

Attachments (1)

📄

467DA92C_D748_4816_84D8_28CBD68FF003_164756.pdf

pdf

Download →
View document text
Date: August 26, 2026 BSE Limited The National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex, Dalal Street, Fort Bandra (East), Mumbai: 400051 Mumbai 400 001 Tel: 022-26598235/ 36/ 452 Fax: (022) 2272 2131 / 2037 / 2061 / 41 Fax: 022-26598237/ 38 Email: corp.relations@bseindia.com Email: takeover@nse.co.in The Board of Directors, Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited) No. 7-1-450/20, Plot No. 04, Mythri Vihar, Ameerpet, Hyderabad, Telangana, 500038 Dear Sir/Madam, Re: Disclosure under Regulation 31(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (“Takeover Code”) Please find enclosed the disclosure under Regulation 31(1) of the Takeover Code with respect to creation of an indirect encumbrance over shares of Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited) (the “Target Company”). For and on behalf of Union (Mauritius) Holdings Limited Name: Dr. Azad Moopen Mandayapurath Authorized Signatory Date: 26 August 2026 Place: Dubai Disclosures under Regulation 31(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 ANNEXURE- 1 Disclosure by the Promoter(s) to the stock exchanges and to the Target Company for creation of encumbrance in terms of Regulation 31(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company (TC): Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited) Names of the stock exchanges where the National Stock Exchange of India Limited and BSE Limited shares of the target company are listed: Date of reporting: August 26, 2026 Name of the promoter or PAC on whose Union (Mauritius) Holdings Limited shares encumbrance has been created/released/invoked: Details of the creation/invocation/release of encumbrance: Creation of indirect encumbrance Name of Promoter Promoter holding Details of events pertaining to encumbrance (3) Post event holding of the holding in the already encumbered shares promoter target company encumbered (2) {creation [(2)+(3)] / (s) or (1) release [(2)-(3)] // PACs invocation [(1)-(3)]] with him Number % of Number % of Type of Date of Type of Reasons for Number % of Name of Number % of total total total event creation/ encumbra encumbrance share the entity share share share (creation / release/ nce capital in whose capital capita capital release / invocation (pledge/ favor l invocation) of lien/ non shares encumbra disposal encumbe nce undertaki red others) Union 1,99,80, 2.29 1,99,80,52.29% Creation of August Pledge Creation of N.A. N.A. DB 1,99,80,5 2.29% (Mauritiu 522 % 22 indirect 24, 2026 pledge over Trustees 22[Please s) encumbran 100% shares (Hong see the Holdings [Please ce of UMHL by Kong) note Limited see the Dr. Azad Limited below*] (“UMHL note Moopen acting as ”) below*] Mandayapur Common ath, Ms. Offshore Alisha Security Moopen, Agent Ms. Naseera for Azad, Ms. Barclays Zeba Azad Bank Moopen and PLC and Ms. Ziham J.P. Moopen as Morgan collateral in Chase favour of DB Bank, Trustees N.A., (Hong London Kong) Branch Limited to (“Lende secure an rs”) existing loan facility of 160,000,000 (“Facility A”) ** and 50,000,000 (“Facility B”) availed by Union Investment Pvt Limited (“UIPL”) from Barclays Bank PLC and J.P. Morgan Chase Bank, N.A., London Branch. *Note: While no new direct encumbrance has been created by UMHL over its shareholding in the Target Company for Facility A and Facility B, existing encumbrances in relation to previous indebtedness continue, which will be immediately released upon completion of conditions stipulated by the Lenders. **Facility A is an existing indebtedness of UIPL where the loan amount has now been increased from USD 145 Million to USD 160 Million Signature of the Authorized Signatory For Union (Mauritius) Holdings Limited Name: Dr. Azad Moopen Mandayapurath Place: Dubai Date: 26 August 2026 Annexure – II Disclosure of reasons for encumbrance Name of listed company Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited) (“Target Company”) Name of the recognised stock exchanges where the shares of the National Stock Exchange of India Limited and BSE Limited company are listed Name of the promoter(s)/PACs whose shares have been Union (Mauritius) Holdings Limited (“UMHL”) encumbered Total promoter shareholding in the listed No. of shares - 1,99,80,522 company % of total share capital 2.29% Encumbered shares as a % of promoter shareholding As on date, the promoter has not created any new encumbrance over its shareholding in the Target Company to secure the term loan facility of USD 160,000,000 (“Facility A”) and the term loan facility of USD 50,000,000 (“Facility B”) each availed by UIPL from Barclays Bank PLC and J.P. Morgan Chase Bank, N.A., London Branch (“Lenders”). However, do note that existing encumbrance in relation to previous indebtedness continues, which will be immediately released upon completion of conditions stipulated by the lenders. 100% shares of UMHL have been pledged by Dr. Azad Moopen Mandayapurath, Ms. Alisha Moopen, Ms. Naseera Azad, Ms. Zeba Azad Moopen and Ms. Ziham Moopen in favour of DB Trustees (Hong Kong) Limited to secure the Facility A and Facility B. Whether encumbered share is 50% or more of promoter Not Applicable [Please refer to note above] shareholding Whether encumbered share is 20% or more of total share capital Not Applicable [Please refer to note above] Details of all the existing events/ agreements pertaining to encumbrance Type of encumbrance (pledge, lien, negative lien, non-disposal Pledge undertaking etc. or any other covenant, transaction, condition or arrangement in the nature of encumbrance) (Date of creation of encumbrance: August 24, 2026) No. of shares encumbered Nil [Please refer to note above] % of shares encumbered Nil [Please refer to note above] Specific details about Name of the entity in whose favour shares DB Trustees (Hong Kong) Limited the encumbrance encumbered (X) Whether the entity X is a scheduled commercial No bank, public financial institution, NBFC or housing finance company? If No, provide the DB Trustees (Hong Kong) Limited is the Common Offshore Security nature of the business of the entity. Agent for Barclays Bank PLC and J.P. Morgan Chase Bank, N.A., London Branch Names of all other entities in the agreement Listed company and its group companies (if any) – Not Applicable Other entities (if any) (parties to share pledge agreement) – 1. Union (Mauritius) Holdings Limited as Borrower 2. Dr. Azad Moopen Mandayapurath, Ms. Alisha Moopen, Ms. Naseera Azad, Ms. Zeba Azad Moopen and Ms. Ziham Moopen as Pledgors 3. DB Trustees (Hong Kong) Limited as the Common Offshore Security Agent Whether the encumbrance is relating to any debt No instruments viz. debenture, commercial paper, certificate of deposit etc.? If yes, provide details about the instrument, including credit rating Security Cover / Asset Value of shares on the date of event / agreement Not Applicable [Please refer to note above] Cover (A) Amount involved (against which shares have been USD 160,000,000 and USD 50,000,000 encumbered) (B) Ratio of A / B Not Applicable [Please refer to note above] End use of Borrowed amount to be utilized for what purpose • Facility A is an existing indebtedness of UIPL where the loan amount has now been increased from USD 145 Million to USD 160 Money (a) Personal use by promoters and PACs Million. The additional indebtedness of USD 15 Million will be utilized towards general corporate purposes of the Borrower (b) For the benefit of listed company overseas. Provide details including amount, • The term loan facility of USD 50,000,000 is proposed to be utilized by UIPL for extending an inter-company loan to UMHL and other purpose of raising money by listed company, purposes as may be permitted by the Lenders. schedule for utilization of amount, repayment schedule etc. (a) Any other reason (please s [Showing first 8,000 characters — download PDF for full document]